April 25, 2019

Transplanting hearts, lungs from HCV-infected donors into recipients without HCV infection

By: Judy Mathias

Editor's Note

In patients without HCV infection who received a heart or lung transplant from HCV-infected donors, treatment with a 4-week antiviral regimen prevented establishment of HCV infection, this study finds.

Of 44 patients enrolled in the study, 36 received lung transplants and 8 received heart transplants. All of the first 35 patients to complete 6 months of follow-up after transplantation were alive and had excellent graft function and an undetectable hepatitis C viral load. The viral load became undetectable at about 2 weeks after transplantation, and it remained undetectable in all patients.

Sponsored Message

More cases of acute cellular rejection for which treatment was indicated occurred in HCV-infected lung-transplant recipients than in those who received lung transplants from donors without HCV infection, but the difference was not significant.

The results show that this can be a successful strategy, and the comparisons with the recipients of heart and lung transplants during the same period who received organs from donors without HCV infection are encouraging. Longer-term data are needed to fully define the risk-benefit profile, the researchers say.


Sign Up For OR a.m.
Sign up for the free OR a.m. eLetter to get news like this in your inbox every morning!

OR Manager Jobs
Live chat by BoldChat